Current Liabilities
Compensation and benefits
Pfizer Compensation and benefits decreased by 24.8% to $2.72B in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
Significant increases may reflect higher headcount, increased compensation, or timing differences in bonus payouts, while decreases could signal cost-cutting or reduced workforce.
Detailed definition
This includes short-term obligations to employees, such as accrued wages, bonuses, vacation pay, and other benefits due...
Peer comparison
Commonly reported by labor-intensive companies, particularly in services and logistics.
Metric ID:
current_liabilities_employee_related_liabilities_currentHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $3.61B | $2.72B |
| QoQ Change | — | -24.8% |
Range$2.72B – $3.61B
Compensation and benefits at Other Companies
Frequently Asked Questions
- What is Pfizer's compensation and benefits?
- Pfizer (PFE) reported compensation and benefits of $2.72B in Q1 2026.
- What does compensation and benefits mean?
- Short-term debts owed to employees for wages, bonuses, and benefits.